Derivative spectrophotometric method for simultaneous determination of clindamycin phosphate and tretinoin in pharmaceutical dosage forms by Maliheh Barazandeh Tehrani et al.
Barazandeh Tehrani et al. DARU Journal of Pharmaceutical Sciences 2013, 21:29
http://www.darujps.com/content/21/1/29RESEARCH ARTICLE Open AccessDerivative spectrophotometric method for
simultaneous determination of clindamycin
phosphate and tretinoin in pharmaceutical
dosage forms
Maliheh Barazandeh Tehrani1*, Melika Namadchian1, Sedigheh Fadaye Vatan2 and Effat Souri1Abstract
A derivative spectrophotometric method was proposed for the simultaneous determination of clindamycin and
tretinoin in pharmaceutical dosage forms. The measurement was achieved using the first and second derivative
signals of clindamycin at (1D) 251 nm and (2D) 239 nm and tretinoin at (1D) 364 nm and (2D) 387 nm.
The proposed method showed excellent linearity at both first and second derivative order in the range of 60–1200
and 1.25–25 μg/ml for clindamycin phosphate and tretinoin respectively. The within-day and between-day
precision and accuracy was in acceptable range (CV<3.81%, error<3.20%). Good agreement between the found and
added concentrations indicates successful application of the proposed method for simultaneous determination of
clindamycin and tretinoin in synthetic mixtures and pharmaceutical dosage form.
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Clindamycin, (methyl-7-chloro-6,7,8-trideoxy-6-{[(4R)-
1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-α-D-
galacto-octopyranoside), (Figure 1) is a semi-synthetic
derivative of lincomycin. Clindamycin reveals potent
activity against many gram-positive and gram-negative
bacterial infections. Topical clindamycin is used for the
treatment of acne vulgaris which typically leads to sup-
pression of cutaneous propionibacterium acnes [1].
Tretinoin, (3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-
nona-2,4,6,8-tetraenoic acid) (Figure 1) is a derivative of vita-
min A. Tretinoin could reduce the hyperkeratinization in the
sebaceous follicle and accordingly decrease the sebum secre-
tion and inflammation [1].
Acne vulgaris is a common dermatologic problem which
could be treated with systemic or topical drugs. More im-
portantly the combination therapy of topical clindamycin* Correspondence: barazand@sina.tums.ac.ir
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distribution, and reproduction in any mediumand tretinoin is more beneficial for the treatment of mild
to moderate stages of acne vulgaris [2].
There are some reported articles in the literature for the
determination of clindamycin [3-8] or tretinoin [9,10]
alone or via the combination of the two drugs [11] by
HPLC and gas chromatography in bulk or in pharmaceut-
ical dosage form. HPLC method has been used in the
USP35- NF30 for determination of clindamycin phosphate
and tretinoin in separate gel dosage form but no simultan-
eous method is reported [12]. The literature survey re-
vealed that although there were some spectrophotometric
methods for the determination of clindamycin [13,14] or
tretinoin [15,16] alone, no validated spectrophotometric
method for simultaneous determination of clindamycin
and tretinoin was reported. The spectrophotometric tech-
nique is a highly preferable method for routine analysis
due to its simplicity and economical advantages. Since the
spectrophotometric quantitative analysis of two or more
compounds with overlapping spectra will likely prove dif-
ficult, thus the derivative spectrophotometry is a fairly
useful method for analysis of a multi-compound mixture.Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Chemical structure of A) Clindamycin phosphate and B) Tretinoin.
Figure 2 Zero-order spectra of clindamycin phosphate (A), tretinoin (B) and overlapped spectra (C).
Figure 3 Derivative spectra of clindamycin phosphate (a) and tretinoin (b); (A) First order spectra (Δλ=16); (B) First order spectra
(Δλ=20); (C) Second order spectra (Δλ=10.5); (D) second order spectra (Δλ=14).
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Linearity range 60–1200 μg/ml 60–1200 μg/ml 60–1200 μg/ml 60–1200 μg/ml
Regression equation Y= 0.000120X-9.761×10-5 Y= 0.000185X-0.00098 Y= 0.00024X-3.912×10-5 Y= 0.0004282X- 0.038
SD of slope 1.41×10-6 1.63×10-7 1.60×10-6 7.80×10-6
RSD of slope (%) 0.170 0.088 0.65 1.82
SD of intercept 0.000839 0.000210 0.003403 0.005001
Correlation coefficient 0.999 0.999 0.998 0.998
* First derivative order.
**Second derivative order.
Barazandeh Tehrani et al. DARU Journal of Pharmaceutical Sciences 2013, 21:29 Page 3 of 7
http://www.darujps.com/content/21/1/29In this study a derivative spectrophotometric method
based on zero-crossing is used for simultaneous determi-
nation of clindamycin and tretinoin.Experimental
Chemicals
Both drugs were favorably provided by Kish Medipharm
Pharmaceutical Co., Kish, Iran. The purity of clindamycin
and tretinoin which were used in the proposed method
was 97.43 and 101.1% respectively based on the standard
USP 32, NF 27 assay method.
The excipients used in the formulation of AcnomisW gel
and a blank gel without active ingredients were also
provided by Kish Medipharm Pharmaceutical Co. NaOH,
methanol and acetonitrile were of analytical grade and
purchased from Merck (Darmstadt, Germany).
The AcnomisW gel containing clindamycin phosphate
(1.2 g/100 g) and tretinoin (25 mg/100 g) was also pre-
pared by Kish Medipharm Pharmaceutical Co.Instruments
A double beam UV-Visible spectrophotometer (160A,
Shimadzu, Japan) with a fixed 2 nm band width and 1 cm
quartz cell were utilized for spectrophotometric measure-
ment. A Waters (Milford,USA)HPLC system (A Model
510 pump, a model 717 plus auto-sampler and a model 418





Linearity range 1.25–25 μg/ml 1.25–25 μ
Regression equation Y= 0.05086X-0.00035 Y= 0.06260X
SD of slope 3.44×10-5 7.12×10
RSD of slope (%) 0.067 0.113
SD of intercept 0.000774 0.00073
Correlation coefficient 0.999 0.999
* First derivative order.
**Second derivative order.Standard solutions
Stock solutions of clindamycin phosphate and tretinoin
were prepared separately in a mixture of methanol and
0.1 M NaOH (50:50) to reach a concentration of 1.2 and
250 μg/ml respectively. Synthetic mixtures of varying
concentration of clindamycin phosphate (60, 120, 240,
360, 480, 720, 960 and 1200 μg/ml) in the presence of
tretinoin (12.5 μg/ml) and also varying concentration of
tretinoin (1.25, 2.5, 5, 7.5, 10, 15, 20 and 25 μg/ml) in
the presence of clindamycin phosphate (600 μg/ml) were
prepared for construction of calibration curves. The
standard solutions of clindamycin and tretinoin in the
synthetic mixtures for determination of relative recovery
were constructed with respect to their ratio in the
pharmaceutical dosage form.
Accuracy and precision
The within-day and between-day precision and accuracy
of the proposed method were calculated by analyzing
three sets of synthetic mixtures of clindamycin phos-
phate and tretinoin in one day and three consecutive
days.
Application of the method in dosage form
A 0.5 g sample of gel formulation containing propylene
glycol, butylated hydroxytoluene, simethicon, clindamycin
phosphate ( 1.2 g/100) and tretinoin (25 mg/100) was







g/ml 1.25–25 μg/ml 1.25–25 μg/ml





Table 3 Accuracy and precision data for determination of clindamycin in the presence of tretinoin (12.5 μg/ml) by
different order derivative spectrophotometry
Added (μg/ml) Within-day (n = 3) Between-day (n = 9)
Found (μg/ml) CV (%) Error (%) Found (μg/ml) CV (%) Error (%)
1D* (Δλ=16)
60.00 60.50±1.58 2.62 0.83 59.96±1.76 2.94 −0.07
480.00 474.31±9.72 2.05 −1.18 479.44±7.89 1.64 −0.11
1200.00 1205.56±1.73 0.14 0.46 1201.55±4.13 0.34 0.13
1D (Δλ=20)
60.00 60.20±0.64 1.07 0.33 59.10±1.09 1.85 −1.49
480.00 482.20±1.30 0.26 0.46 480.99±2.40 0.50 0.20
1200.00 1203.68±2.12 0.18 0.30 1205.51±2.18 0.18 0.46
2D** (Δλ=10.5)
60.00 60.81±2.20 3.61 1.35 59.91±1.72 2.88 −0.14
480.00 480.06±16.34 3.40 0.01 471.36±18.00 3.81 −1.80
1200.00 1201.46±6.50 0.54 0.12 1201.87±9.63 0.80 0.15
2D (Δλ=14)
60.00 60.23±1.40 2.32 0.38 61.36±1.80 2.93 2.26
480.00 467.14±3.70 0.80 −2.67 465.89±4.06 0.87 −2.94
1200.00 1215.98±18.00 1.48 1.33 1224.42±11.96 0.97 2.03
* First derivative order.
**Second derivative order.
Table 4 Accuracy and precision data for determination of tretinoin in the presence of clindamycin (600 μg/ml) by
different order derivative spectrophotometry
Added (μg/ml) Within-day (n = 3) Between-day (n = 9)
Found (μg/ml) CV (%) Error (%) Found (μg/ml) CV (%) Error (%)
1D* (Δλ=16)
1.25 1.22±0.02 1.64 −2.37 1.21±0.02 1.63 −3.2
5.00 4.88±0.004 0.09 −2.38 4.88±0.01 0.21 −2.38
15.00 14.98±0.081 0.54 −0.13 14.95±0.05 0.34 −0.33
1D (Δλ=20)
1.25 1.27±0.008 0.64 1.60 1.26±0.01 1.02 0.80
5.00 4.85±0.018 0.37 −2.94 4.84±0.02 0.41 −3.20
15.00 15.02±0.036 0.24 0.13 15.00±0.03 0.21 0.00
2D** (Δλ=10.5)
1.25 1.23±0.02 1.61 −1.60 1.23±0.03 2.44 −1.60
5.00 4.86±0.062 1.28 −2.8 4.89±0.08 1.64 −2.23
15.00 15.35±0.11 0.72 2.33 15.39±0.16 1.07 2.64
2D (Δλ=14)
1.25 1.22±0.002 0.16 −2.40 1.21±0.02 1.65 −3.20
5.00 4.97±0.005 0.11 −0.60 4.88±0.08 1.67 −2.37
15.00 15.29±0.40 2.62 1.93 15.39±0.49 3.18 2.63
* First derivative order.
**Second derivative order.
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1D* (Δλ =16) 99.3 ± 1.6 98.3 ± 1.3
1D (Δλ =20) 98.5 ± 2.6 97.3 ± 2.6
2D** (Δλ =10.5) 98.6 ± 1.4 95.6 ± 1.9
2D (Δλ =14) 95.2 ± 4.9 94.3 ± 0.5
* First derivative order.
**Second derivative order.
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NaOH (50:50) by sonicating for 10 min. The mixture was
made up to required volume with the same solvent and
centrifuged for 10 min at 4000 rpm. The clear solution
was used for determination of clindamycin and tretinoin
by the proposed method and also pharmacopoeial method
reported for determination of clindamycin or tretinoin
alone. A solution of blank gel treated by the same proced-
ure was used as blank in spectrophotometric method.
Results and discussion
Selection of solvent
Tretinoin was not soluble in water. Both clindamycin and
tretinoin were soluble in alcohol and chloroform but their
solubility in non-aqueous solvents was lower than in
methanol [17]. Their solubility was improved by adding
NaOH to the methanol and consequently, a mixture of
methanol and 0.1 M NaOH (50:50) was selected as a
proper solvent to prepare the standard solutions.
Absorption spectra
The zero-order spectra of clindamycin (600 μg/ml) and
tretinoin (12.5 μg/ml) solutions were separately mea-
sured at 200–500 nm using the solvent (methanol:
0.1 M NaOH 50:50) as a blank.
To give a clear picture, the absorption spectra of
clindamycin phosphate and tretinoin are shown in Figure 2
where the zero-order spectra demonstrated a marked




UV/VIS 1D* (Δλ=16) 1.16± 0.03
1D (Δλ=20) 1.15± 0.06
2D** (Δλ=10.5) 1.14±0.03
2D (Δλ=14) 1.16± 0.02
HPLC 1.15±0.07
* First derivative order.
**Second derivative order.two drugs will not be possible by direct measurement of
absorbance signals. The first to fourth order derivative
spectra of those solutions were obtained in the same range
at different Δλ values.
Zero-crossing points were assigned from the first to
fourth order derivative spectra of clindamycin and tre-
tinoin. The suitable zero-crossing points were selected
based on the best linear response to the clindamycin
concentration in the presence of tretinoin or the tretin-
oin concentration in the presence of clindamycin.Selection of suitable wavelengths
As it is shown in Figure 3, the first and second order spec-
tra of clindamycin and tretinoin revealed zero-crossing
points for their simultaneous determination. The zero-
crossing points of clindamycin and tretinoin in the first
order derivative were found to be 252 (Δλ=16), 251
(Δλ=20) and 364 nm (Δλ=16) and in the second order de-
rivative were 234(Δλ=10.5), 239 nm (Δλ=14) and 386
(Δλ=10.5), 387 nm (Δλ=14) respectively.Method validation
The validation was done according to ICH recommen-
dations for linearity, range, accuracy and precision, limit
of detection (LOD), limit of quantification (LOQ) ro-
bustness and relative recovery [18].Linearity
To verify the validation of Beer’s law, six series of cali-
bration curves were plotted using the first and second
order spectra in the range of 60–1200 μg/ml and 1.25–
25 μg/ml for clindamycin and tretinoin respectively.
The results of calibration curves in four different Δλ
and wavelengths are given in Table 1 and 2. These data
illustrate that the first and second derivative spectra
measurements with Δλ = 16, 20, 10.5 and 14 can be
meaningfully usable. The correlation coefficient of the
calibration curves (n=6) for both drugs in all wave-
lengths was greater than 0.998%.retinoin (25 mg) using derivative spectrophotometry and
(g/100) Tretinoin (mg/100)
(%) Recovery Mean± SD (%) Recovery
96.66 24.54± 0.03 98.16
95.83 24.85± 0.03 99.40
95.00 24.11± 0.02 96.44
96.67 23.95± 0.06 95.80
95.83 24.62±0.97 98.49
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values of y-intercepts close to zero indicate the good lin-
earity of the calibrations.
Accuracy and precision
In order to study the accuracy and precision, the proposed
method was applied for simultaneous determination of
varying concentrations of clindamycin (60, 480 and
1200 μg/ml) in the presence of tretinoin (12.5 μg/ml) and
varying concentrations of tretinoin (1.25, 5 and 15 μg/ml)
in the presence of clindamycin (600 μg/ml). The within-
day and between-day precision and accuracy were calcu-
lated (Tables 3 and 4).
The percentage of coefficients of variations obtained
was in the range of 0.09–3.81 and the percent of error
was lower than 3.2% for both drugs in all the three se-
lected concentrations which indicate good accuracy and
precision of the method.
Limit of detection & limit of quantification
The limit of detection measured based on the standard
deviation of the response and slope, was in the range
of 3.4-42.5 μg/ml and 0.05–0.42 μg/ml in the first and
second derivative order for clindamycin phosphate and
tretinoin respectively. The quantitation limit was 60 μg/ml
for clindamycin phosphate and 1.25 μg/ml for tretinoin.
Robustness
The robustness of the proposed method was assessed by
changes in the ratio of methanol and NaOH and also
the molarity of NaOH up to 10 percent. There was no
significant difference between the results.
Relative recovery
The recovery was determined using standard addition
method. The recoveries in different derivative conditions
ranged from 94.3 to 98.3% for clindamycin and 95.2–
99.3% for tretinoin (Table 5).
Application
The proposed method was applied successfully for the
analysis of clindamycin and tretinoin in pharmaceutical
dosage form (AcnomisW gel) containing 1.2 g clindamycin
and 25 mg tretinoin (Table 6). The results obtained from
the first and second derivative order indicate the percent-
age of recovery to be between 94.3-99.3 in all evaluations.
This technique of analysis was compared with a HPLC
method [11]. Using the two-tailed t-test method it was re-
vealed that there was no significant difference between the
results obtained from these two methods (p-value>0.05).
Conclusion
It was concluded that the first and second order deriva-
tive UV spectrophotometric method at Δλ= 16, 20, 10.5and 14 could be used for simultaneous determination of
clindamycin phosphate and tretinoin in their combined
pharmaceutical products. This method could be used for
rapid analysis of active ingredients in process and for
quality control samples.
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